Journal of Medicinal Chemistry p. 1291 - 1295 (1985)
Update date:2022-08-04
Topics:
Roark, W. Howard
Tinney, Francis J.
Cohen, David
Essenburg, Arnold D.
Kaplan, Harvey R.
A series of non-sulfhydryl modified dipeptides related to CI-906, CI-907 and enalapril was prepared in which various isosteric moieties (O, S, SO, SO2) have been substituted for the amino group and in which the proline residue has been replaced with various hydrophobic amino acids.The compounds were evaluated in vivo for inhibition of angiotensin-converting enzyme and in vitro for antihypertensive activity.Compound 7c, the most potent member of this series, had an in vitro IC50 1.4*10-8 M and showed modest oral antihypertensive activity at 30 mg/kg in conscious, two kidney, one clip Goldblatt hypertensive rats.Structure-activity relationships are discussed.
View Morejintan yufan Medicine Raw materials Co.,Ltd.(expird)
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
Changde Yungang Biotechnology Co., Ltd
website:http://www.cdyg.com
Contact:+86-736-7391178
Address:Qiaonan Industrial Park, Changde City, Hunan Province
Wuhan Kemi-Works Chemical Co., Ltd
website:http://www.kemiworks.com
Contact:86-27-85736489
Address:Rm. 1503, No. 164, Jianghan North Rd., Wuhan, 430022 China
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Zibo Shiji Zhonglian Pharmaceutical Technology Co., Ltd.
Contact:+86-533-3075187
Address:66 Xin'er Road, Linzi District, Zibo City, Shandong, China
Doi:10.1016/S0040-4020(01)86070-1
(1988)Doi:10.1039/c39860000597
(1986)Doi:10.1021/acs.joc.0c01955
(2020)Doi:10.1002/cjoc.201900296
(2019)Doi:10.1021/jo00219a038
(1985)Doi:10.1039/jr9340000818
(1934)